Trial Search Results

Efficacy of Diuretics in Kidney Disease

This study will determine the efficacy of diuretics in patients with chronic kidney disease.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Drug: Metolazone
  • Drug: Placebo

Phase:

Phase 2

Eligibility


Inclusion Criteria:

   - stable chronic kidney disease patients able to provide consent

   - stable dialysis patients who produce urine and able to provide consent

Exclusion Criteria:

   - use of antibiotics for last two months or expected antibiotic use

   - recent hospitalization or other event resulting in instability of food intake

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Tammy Sirich, MD
650-493-5000
Not Recruiting